Cytoskeleton Structure and Dynamic Behaviour: Quick Excursus from Basic Molecular Mechanisms to Some Implications in Cancer Chemotherapy
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Plakins, a Versatile Family of Cytolinkers: Roles in Skin Integrity and in Human Diseases Jamal-Eddine Bouameur1,2, Bertrand Favre1 and Luca Borradori1
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REVIEW Plakins, a Versatile Family of Cytolinkers: Roles in Skin Integrity and in Human Diseases Jamal-Eddine Bouameur1,2, Bertrand Favre1 and Luca Borradori1 The plakin family consists of giant proteins involved in in (Roper et al., 2002; Jefferson et al., 2004; Sonnenberg and the cross-linking and organization of the cytoskeleton Liem, 2007; Boyer et al., 2010; Suozzi et al., 2012). and adhesion complexes. They further modulate sev- Mammalian plakins share a similar structural organization eral fundamental biological processes, such as cell and comprise seven members: bullous pemphigoid antigen 1 adhesion, migration, and polarization or signaling (BPAG1), desmoplakin, envoplakin, epiplakin, microtubule- pathways. Inherited and acquired defects of plakins actin cross-linking factor 1 (MACF1), periplakin, and plectin in humans and in animal models potentially lead to (Figure 1) (Choi et al., 2002; Jefferson et al., 2007; Choi and dramatic manifestations in the skin, striated muscles, Weis, 2011; Ortega et al., 2011). The existence of develop- and/or nervous system. These observations unequivo- mentally regulated and tissue-specific splice variants of some cally demonstrate the key role of plakins in the plakins further increases the diversity and versatility of these proteins (Table 1; Figure 1; Leung et al., 2001; Rezniczek et al., maintenance of tissue integrity. Here we review the 2003; Lin et al., 2005; Jefferson et al., 2006; Cabral et al., 2010). characteristics of the mammalian plakin members BPAG1 (bullous pemphigoid antigen 1), desmoplakin, PLAKINS IN THE EPIDERMIS plectin, envoplakin, epiplakin, MACF1 (microtubule- Epithelial BPAG1 (BPAG1e, also called BP230) constitutes the actin cross-linking factor 1), and periplakin, highlight- epithelium-specific isoform of BPAG1 and is localized in basal ing their role in skin homeostasis and diseases. -
Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance
cells Review Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance Ronay Cetin 1,† , Eva Quandt 2,† and Manuel Kaulich 1,3,4,* 1 Institute of Biochemistry II, Goethe University Frankfurt-Medical Faculty, University Hospital, 60590 Frankfurt am Main, Germany; [email protected] 2 Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, 08195 Barcelona, Spain; [email protected] 3 Frankfurt Cancer Institute, 60596 Frankfurt am Main, Germany 4 Cardio-Pulmonary Institute, 60590 Frankfurt am Main, Germany * Correspondence: [email protected]; Tel.: +49-(0)-69-6301-5450 † These authors contributed equally to this work. Abstract: Drug resistance is a commonly unavoidable consequence of cancer treatment that results in therapy failure and disease relapse. Intrinsic (pre-existing) or acquired resistance mechanisms can be drug-specific or be applicable to multiple drugs, resulting in multidrug resistance. The presence of drug resistance is, however, tightly coupled to changes in cellular homeostasis, which can lead to resistance-coupled vulnerabilities. Unbiased gene perturbations through RNAi and CRISPR technologies are invaluable tools to establish genotype-to-phenotype relationships at the genome scale. Moreover, their application to cancer cell lines can uncover new vulnerabilities that are associated with resistance mechanisms. Here, we discuss targeted and unbiased RNAi and CRISPR efforts in the discovery of drug resistance mechanisms by focusing on first-in-line chemotherapy and their enforced vulnerabilities, and we present a view forward on which measures should be taken to accelerate their clinical translation. Citation: Cetin, R.; Quandt, E.; Kaulich, M. Functional Genomics Keywords: chemotherapy resistance; cancer and drug vulnerabilities; functional genomics; RNAi Approaches to Elucidate Vulnerabilities of Intrinsic and and CRISPR screens Acquired Chemotherapy Resistance. -
The Transition from Primary Colorectal Cancer to Isolated Peritoneal Malignancy
medRxiv preprint doi: https://doi.org/10.1101/2020.02.24.20027318; this version posted February 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with a hypermutant, hypermethylated state Sally Hallam1, Joanne Stockton1, Claire Bryer1, Celina Whalley1, Valerie Pestinger1, Haney Youssef1, Andrew D Beggs1 1 = Surgical Research Laboratory, Institute of Cancer & Genomic Science, University of Birmingham, B15 2TT. Correspondence to: Andrew Beggs, [email protected] KEYWORDS: Colorectal cancer, peritoneal metastasis ABBREVIATIONS: Colorectal cancer (CRC), Colorectal peritoneal metastasis (CPM), Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS & HIPEC), Disease free survival (DFS), Differentially methylated regions (DMR), Overall survival (OS), TableFormalin fixed paraffin embedded (FFPE), Hepatocellular carcinoma (HCC) ARTICLE CATEGORY: Research article NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. 1 medRxiv preprint doi: https://doi.org/10.1101/2020.02.24.20027318; this version posted February 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . NOVELTY AND IMPACT: Colorectal peritoneal metastasis (CPM) are associated with limited and variable survival despite patient selection using known prognostic factors and optimal currently available treatments. -
Bioinformatics Analysis of Potential Key Genes and Mechanisms in Type 2 Diabetes Mellitus Basavaraj Vastrad1, Chanabasayya Vastrad*2
bioRxiv preprint doi: https://doi.org/10.1101/2021.03.28.437386; this version posted March 29, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Bioinformatics analysis of potential key genes and mechanisms in type 2 diabetes mellitus Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karnataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2021.03.28.437386; this version posted March 29, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Type 2 diabetes mellitus (T2DM) is etiologically related to metabolic disorder. The aim of our study was to screen out candidate genes of T2DM and to elucidate the underlying molecular mechanisms by bioinformatics methods. Expression profiling by high throughput sequencing data of GSE154126 was downloaded from Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) between T2DM and normal control were identified. And then, functional enrichment analyses of gene ontology (GO) and REACTOME pathway analysis was performed. Protein–protein interaction (PPI) network and module analyses were performed based on the DEGs. Additionally, potential miRNAs of hub genes were predicted by miRNet database . Transcription factors (TFs) of hub genes were detected by NetworkAnalyst database. Further, validations were performed by receiver operating characteristic curve (ROC) analysis and real-time polymerase chain reaction (RT-PCR). -
Is the Cytoskeleton Necessary for Viral Replication?
Georgia State University ScholarWorks @ Georgia State University Biology Theses Department of Biology Summer 7-9-2012 Is the Cytoskeleton Necessary for Viral Replication? Rachel E. Morgan Georgia State University Follow this and additional works at: https://scholarworks.gsu.edu/biology_theses Recommended Citation Morgan, Rachel E., "Is the Cytoskeleton Necessary for Viral Replication?." Thesis, Georgia State University, 2012. https://scholarworks.gsu.edu/biology_theses/38 This Thesis is brought to you for free and open access by the Department of Biology at ScholarWorks @ Georgia State University. It has been accepted for inclusion in Biology Theses by an authorized administrator of ScholarWorks @ Georgia State University. For more information, please contact [email protected]. IS THE CYTOSKELETON NECESSARY FOR VIRAL REPLICATION? By RACHEL MORGAN Under the Direction of Dr. Teryl Frey ABSTRACT The cytoskeleton plays an important role in trafficking proteins and other macromolecular moieties throughout the cell. Viruses have been thought to depend heavily on the cytoskeleton for their replication cycles. However, studies, including one in our lab, found that some viruses are not inhibited by anti-microtubule drugs. This study was undertaken to evaluate the replication of viruses from several families in the presence of cytoskeleton- inhibiting drugs and to examine the intracellular localization of the proteins of one of these viruses, Sindbis virus, to test the hypothesis that alternate pathways are used if the cytoskeleton is inhibited. We found that Sindbis virus (Togaviridae, positive-strand RNA), vesicular stomatitis virus (Rhabdoviridae, negative-strand RNA), and Herpes simplex virus 1 (Herpesviridae, DNA virus) were not inhibited by these drugs, contrary to expectation. Differences in the localization of the Sindbis virus were observed, suggesting the existence of alternate pathways for intracellular transport. -
Supplementary Information
Supplementary information Supplementary Discussion Radiation therapy is one of the key modalities in the management of HNSCC. As of today about 75% of patients with HNSCC are treated with radiotherapy alone or in adjuvant setting after surgery (1). Nevertheless, only few biological parameters have been identified so far as potent prognostic biomarkers for radiotherapy outcome and as potential targets for personalized treatment approaches of radiotherapy combined with targeted drugs. Markers for radiosensitivity include HPV positivity, which has been associated with improved survival and loco-regional control (2-4). On the other hand, tumor volume, the number and intrinsic radioresistance of CSC as well as tumor hypoxia and repopulation were shown to be associated with tumor radioresistance (2, 5- 12) . The tumor growth is maintained by a population of CSC which have unlimited self- renewal potential and cause tumor recurrence if not eradicated by treatment. The number of CSC is a promising biomarker for local tumor control especially for the primary RCTx setting when the number of CSC correlates with primary tumor volumes (8, 9). The tumor suppressor p53 is a key regulator of energy metabolism (13). Mutations in p53 are ubiquitous in HPV negative HNSCC (14). Cal33 HNSCC cells, which were used for the SLC3A2 gene knockout, harbour a p53R175H mutation, which has oncogenic functions and promotes tumor progression (15). A recent study showed that inducible expression of p53R175H in tumor cells increases mitochondrial oxygen consumption and cell proliferation as well as decreasing intracellular ROS levels (16). Interestingly, previous studies demonstrated that the p53R175H mutation prevents cell 1 cycle arrest and apoptosis by attenuation of the expression of stress related gene ATF3 (17, 18). -
Cytoskeletal Proteins in Neurological Disorders
cells Review Much More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders Diana C. Muñoz-Lasso 1 , Carlos Romá-Mateo 2,3,4, Federico V. Pallardó 2,3,4 and Pilar Gonzalez-Cabo 2,3,4,* 1 Department of Oncogenomics, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands; [email protected] 2 Department of Physiology, Faculty of Medicine and Dentistry. University of Valencia-INCLIVA, 46010 Valencia, Spain; [email protected] (C.R.-M.); [email protected] (F.V.P.) 3 CIBER de Enfermedades Raras (CIBERER), 46010 Valencia, Spain 4 Associated Unit for Rare Diseases INCLIVA-CIPF, 46010 Valencia, Spain * Correspondence: [email protected]; Tel.: +34-963-395-036 Received: 10 December 2019; Accepted: 29 January 2020; Published: 4 February 2020 Abstract: Recent observations related to the structure of the cytoskeleton in neurons and novel cytoskeletal abnormalities involved in the pathophysiology of some neurological diseases are changing our view on the function of the cytoskeletal proteins in the nervous system. These efforts allow a better understanding of the molecular mechanisms underlying neurological diseases and allow us to see beyond our current knowledge for the development of new treatments. The neuronal cytoskeleton can be described as an organelle formed by the three-dimensional lattice of the three main families of filaments: actin filaments, microtubules, and neurofilaments. This organelle organizes well-defined structures within neurons (cell bodies and axons), which allow their proper development and function through life. Here, we will provide an overview of both the basic and novel concepts related to those cytoskeletal proteins, which are emerging as potential targets in the study of the pathophysiological mechanisms underlying neurological disorders. -
Types I and II Keratin Intermediate Filaments
Downloaded from http://cshperspectives.cshlp.org/ on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press Types I and II Keratin Intermediate Filaments Justin T. Jacob,1 Pierre A. Coulombe,1,2 Raymond Kwan,3 and M. Bishr Omary3,4 1Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205 2Departments of Biological Chemistry, Dermatology, and Oncology, School of Medicine, and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland 21205 3Departments of Molecular & Integrative Physiologyand Medicine, Universityof Michigan, Ann Arbor, Michigan 48109 4VA Ann Arbor Health Care System, Ann Arbor, Michigan 48105 Correspondence: [email protected] SUMMARY Keratins—types I and II—are the intermediate-filament-forming proteins expressed in epithe- lial cells. They are encoded by 54 evolutionarily conserved genes (28 type I, 26 type II) and regulated in a pairwise and tissue type–, differentiation-, and context-dependent manner. Here, we review how keratins serve multiple homeostatic and stress-triggered mechanical and nonmechanical functions, including maintenance of cellular integrity, regulation of cell growth and migration, and protection from apoptosis. These functions are tightly regulated by posttranslational modifications and keratin-associated proteins. Genetically determined alterations in keratin-coding sequences underlie highly penetrant and rare disorders whose pathophysiology reflects cell fragility or altered -
Estrogen-Related Receptor Gamma Promotes Mesenchymal-To-Epithelial Transition and Suppresses Breast Tumor Growth
Author Manuscript Published OnlineFirst on February 21, 2011; DOI: 10.1158/0008-5472.CAN-10-1315 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Estrogen-Related Receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growth Claire Tiraby, Bethany C. Hazen, Marin L. Gantner, and Anastasia Kralli† Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, USA Running title: ERRγ induces MET and suppresses breast tumor growth Keywords: breast cancer, mesenchymal-to-epithelial transition, estrogen-related receptor, E-cadherin regulation Funded by the California Breast Cancer Research Program (12IB-0010) and the Department of Defense Breast Cancer Research Program (W81XWH-09-1-0327). †Corresponding author: Anastasia Kralli Department of Chemical Physiology The Scripps Research Institute 10550 North Torrey Pines Road La Jolla, CA 92037 Tel. 858 7847287 Fax. 858 7849132 E-mail: [email protected] Downloaded from cancerres.aacrjournals.org on October 1, 2021. © 2011 American Association for Cancer Research. Author Manuscript Published OnlineFirst on February 21, 2011; DOI: 10.1158/0008-5472.CAN-10-1315 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract Estrogen-Related Receptors alpha (ERRα) and gamma (ERRγ) are orphan nuclear receptors implicated in breast cancer that function similarly in the regulation of oxidative metabolism genes. Paradoxically, in clinical studies high levels of ERRα are associated with poor outcomes whereas high levels of ERRγ are associated with a favorable course. Recent studies suggest that ERRα may indeed promote breast tumor growth. The roles of ERRγ in breast cancer progression and how ERRα and ERRγ may differentially affect cancer growth are unclear. -
The Spectrin Superfamily
Downloaded from http://cshperspectives.cshlp.org/ on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press Cytoskeletal Integrators: The Spectrin Superfamily Ronald K.H. Liem Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York 10032 Correspondence: [email protected] SUMMARY This review discusses the spectrin superfamily of proteins that function to connect cytoskeletal elements to each other, the cell membrane, and the nucleus. The signature domain is the spectrin repeat, a 106–122-amino-acid segment comprising three a-helices. a-actinin is considered to be the ancestral protein and functions to cross-link actin filaments. It then evolved to generate spectrin and dystrophin that function to link the actin cytoskeleton to the cell membrane, as well as the spectraplakins and plakins that link cytoskeletal elements to each other and to junctional complexes. A final class comprises the nesprins, which are able to bind to the nuclear membrane. This review discusses the domain organization of the various spectrin family members, their roles in protein–protein interactions, and their roles in disease, as determined from mutations, and it also describes the functional roles of the family members as determined from null phenotypes. Outline 1 Introduction 5 Spectraplakins and plakins 2 a-actinin 6 Nesprins 3 Spectrins 7 Concluding remarks 4 Dystrophin and utrophin References Editors: Thomas D. Pollard and Robert D. Goldman Additional Perspectives on The Cytoskeleton available at www.cshperspectives.org Copyright # 2016 Cold Spring Harbor Laboratory Press; all rights reserved; doi: 10.1101/cshperspect.a018259 Cite this article as Cold Spring Harb Perspect Biol 2016;8:a018259 1 Downloaded from http://cshperspectives.cshlp.org/ on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press R.K.H. -
| Oa Tai Ei to Ka Marratu Wa Kitu
|OA TAI EI US009855317B2TO KAMARRATU WA KITU (12 ) United States Patent ( 10 ) Patent No. : US 9 , 855 ,317 B2 Bright (45 ) Date of Patent: Jan . 2 , 2018 ( 54 ) SYSTEMS AND METHODS FOR ( 56 ) References Cited SYMPATHETIC CARDIOPULMONARY NEUROMODULATION U . S . PATENT DOCUMENTS 4 ,029 ,793 A 6 / 1977 Adams et al. (71 ) Applicant : Reflex Medical, Inc. , Los Altos Hills , 4 , 582 , 865 A 4 / 1986 Balazs et al. CA (US ) 6 , 545, 067 B1 4 / 2003 Büchner et al. 6 , 746, 464 B1 6 / 2004 Makower 6 , 932, 971 B2 8 / 2005 Bachmann et al. ( 72 ) Inventor: Corinne Bright , Los Altos Hills , CA 6 , 937 , 896 B1 8 / 2005 Kroll (US ) 7 , 928 ,141 B2 4 / 2011 Li 8 , 175 , 711 B2 5 / 2012 Demarais et al . ( 73 ) Assignee : Reflex Medical , Inc ., Los Altos Hills , 8 , 206 , 299 B2 6 / 2012 Foley et al . 8 , 211 , 017 B2 7 / 2012 Foley et al . CA (US ) 8 ,465 , 752 B2 6 / 2013 Seward 8 , 480, 651 B2 7 / 2013 Abuzaina et al . ( * ) Notice : Subject to any disclaimer, the term of this 8 , 708, 995 B2 4 / 2014 Seward et al. patent is extended or adjusted under 35 9 , 011 , 879 B2 4 / 2015 Seward U . S . C . 154 (b ) by 0 days. 9 , 199 ,065 B2 12 /2015 Seward 2002 /0037919 AL 3 / 2002 Hunter 2005 /0228460 A110 / 2005 Levin et al . ( 21 ) Appl. No. : 15 /140 ,254 2005 /0261672 AL 11 /2005 Deem et al . (22 ) Filed : Apr. 27 , 2016 2006 /0280797 Al 12 /2006 Shoichet et al. (Continued ) (65 ) Prior Publication Data US 2016 /0317621 A1 Nov . -
Genetic Variation and Functional Analysis of the Cardiomedin Gene
TECHNISCHE UNIVERSITÄT MÜNCHEN LEHRSTUHL FÜR EXPERIMENTELLE GENETIK Genetic Variation and Functional Analysis of the Cardiomedin Gene Zasie Susanne Schäfer Vollständiger Abdruck der von der Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften genehmigten Dissertation. Vorsitzende: Univ.-Prof. A. Schnieke, Ph.D. Prüfer der Dissertation: 1. apl. Prof. Dr. J. Adamski 2. Univ.-Prof. Dr. Dr. H.-R. Fries 3. Univ.-Prof. Dr. Th. Meitinger Die Dissertation wurde am. 31.05.2011 bei der Technischen Universität München eingereicht und durch die Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt am 02.04.2012 angenommen. Table of Contents Table of contents Abbreviations ........................................................................................................................ 7 1. Summary ..........................................................................................................................10 Zusammenfassung ...............................................................................................................11 2. Introduction ......................................................................................................................12 2.1 Genome-wide association studies (GWAS) and post-GWAS functional genomics ......12 2.2 Genetic influences on cardiac repolarization and sudden cardiac death syndrome in GWAS and the chromosome